FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Gen Virol / Comparative clinical, virological and pathological character...
The Journal of general virology2025; 106(6); 002110; doi: 10.1099/jgv.0.002110

Comparative clinical, virological and pathological characterization of equine rotavirus A G3P[12] and G14P[12] infection in neonatal mice.

Abstract: Group A rotavirus (RVA) infections are a leading cause of neonatal diarrhoea in foals. Neonatal mice could serve as a useful tool to study the pathogenesis of equine RVA (ERVA) as well as a preclinical model for assessment of vaccine efficacy. This study aimed to comparatively evaluate the clinical, virological and pathological features of ERVA G3P[12] and G14P[12] infection in neonatal mice and compare them with porcine OSU G5P[7] and bovine UK G6P[5] RVA reference strains. Neonatal mice orally inoculated with equine, bovine and porcine RVA developed short-lived diarrhoea at variable rates, G14P[12] (61%) and G3P[12] (88%). Viral replication kinetics for all strains were characterized by a gradual decline in viral load to levels below the limit of detection by 72-96 h post-infection (hpi), in line with the reduction in the number of infected enterocytes demonstrated via RNAscope hybridization. Importantly, the clinical and viral replication kinetics correlated with significant microscopic intestinal alterations characterized by enterocyte vacuolation, scalloping and hyperplasia with a peak occurring at 48 hpi and persisting until at least 96 hpi. Overall, neonatal mice develop a disease phenotype of short duration following infection with equine, porcine and bovine RVA strains characterized by diarrhoea and pronounced histological alterations in the intestinal villi. The limited intestinal viral replication is likely associated with host restriction. The clinical and pathological phenotypes developed by neonatal mice following experimental infection could serve as a preclinical tool to assess vaccine efficacy and for pathogenesis studies involving RVA of equine, porcine and bovine origin.
Get Full Text
Publication Date: 2025-06-05 PubMed ID: 40471657PubMed Central: PMC12141749DOI: 10.1099/jgv.0.002110Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Comparative Study

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Equine rotavirus A (ERVA) is a common cause of neonatal diarrhea in foals. The research article examines the clinical, virological and pathological features of two strains of ERVA in neonatal mice for comparative study and to establish mice as a preclinical model for vaccine efficacy assessment.

Rotavirus A and Methods of Study

  • RotaVirus A (RVA) is a leading cause of diarrhea in newborn foals, which can be life-threatening.
  • The study uses two strains of RVA, namely ERVA G3P[12] and G14P[12].
  • The study also uses two reference strains for comparison, porcine OSU G5P[7] and bovine UK G6P[5] RVA.
  • The study aims to evaluate and compare the clinical, virological, and pathological characteristics of these four strains.

Infection in Neonatal Mice

  • Neonatal mice were orally inoculated with each of the four RVA strains to study the progress of the disease.
  • Upon infection, the mice developed diarrhea at varying rates. Mice infected with G14P[12] developed diarrhea at a rate of 61%, while those infected with G3P[12] developed diarrhea at a higher rate of 88%.
  • The viral replication kinetics for all strains showed a gradual decline to levels below the limit of detection by 72-96 hours post infection (hpi).
  • This decline corresponded with the reduction in the number of infected enterocytes, the cells of the intestinal lining.

Microscopic Intestinal Alterations

  • The clinical and viral replication kinetics were found to correlate with microscopic intestinal alterations.
  • These alterations involve enterocyte vacuolation (formation of vacuoles, or empty spaces), scalloping (making of indented or wavy edges), and hyperplasia (production of new cells).
  • The peak for these alterations was observed at 48 hours post infection, persisting up to 96 hours.

Outcomes and Future Research

  • The neonatal mice developed a short-duration disease phenotype characterized by diarrhea and significant physiological changes in the intestinal tract due to infection with the four RVA strains.
  • According to the researchers, the limited duration of intestinal viral replication might have been due to the host’s restriction.
  • The study concludes that this disease phenotype could serve as a tool to assess the effectiveness of vaccines and the pathogenesis of RVA in equines, porcines, and bovines.

Cite This Article

APA
Gamage C, Holl W, Parreño V, Thieulent CJ, Balasuriya UBR, Vissani MA, Barrandeguy ME, Carossino M. (2025). Comparative clinical, virological and pathological characterization of equine rotavirus A G3P[12] and G14P[12] infection in neonatal mice. J Gen Virol, 106(6), 002110. https://doi.org/10.1099/jgv.0.002110

Publication

The Journal of general virology
ISSN: 1465-2099
NlmUniqueID: 0077340
Country: England
Language: English
Volume: 106
Issue: 6
PII: 002110

Researcher Affiliations

Gamage, Chandika
  • Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Holl, William
  • Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
  • Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Parreño, Viviana
  • Instituto de Virología, CICVyA, Instituto Nacional de Tecnología Agropecuaria (INTA), Buenos Aires B1686, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires C1425, Argentina.
Thieulent, Côme J
  • Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Balasuriya, Udeni B R
  • Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Vissani, M Aldana
  • Instituto de Virología, CICVyA, Instituto Nacional de Tecnología Agropecuaria (INTA), Buenos Aires B1686, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires C1425, Argentina.
  • Escuela de Veterinaria, Universidad del Salvador, Buenos Aires B1630, Argentina.
Barrandeguy, Maria E
  • Plataforma de Salud Animal, Instituto Nacional de Investigación Agropecuaria (INIA), La Estanzuela, Semillero, Uruguay.
Carossino, Mariano
  • Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
  • Louisiana Animal Disease Diagnostic Laboratory, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.

MeSH Terms

  • Animals
  • Rotavirus Infections / virology
  • Rotavirus Infections / pathology
  • Rotavirus Infections / veterinary
  • Rotavirus / genetics
  • Rotavirus / classification
  • Rotavirus / physiology
  • Rotavirus / pathogenicity
  • Rotavirus / isolation & purification
  • Mice
  • Animals, Newborn
  • Horses
  • Cattle
  • Swine
  • Diarrhea / virology
  • Diarrhea / pathology
  • Diarrhea / veterinary
  • Virus Replication
  • Disease Models, Animal
  • Viral Load
  • Horse Diseases / virology
  • Horse Diseases / pathology

Conflict of Interest Statement

The authors declare that there are no conflicts of interest.

References

This article includes 65 references
  1. Matthijnssens J, Attoui H, Bányai K, Brussaard CPD, Danthi P. ICTV virus taxonomy profile: Sedoreoviridae 2022. J Gen Virol 2022;103:10.
    doi: 10.1099/jgv.0.001782pubmed: 36215107google scholar: lookup
  2. Matthijnssens J, Ciarlet M, Heiman E, Arijs I, Delbeke T. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol 2008;82:3204–3219.
    doi: 10.1128/JVI.02257-07pmc: PMC2268446pubmed: 18216098google scholar: lookup
  3. Du Y, Chen C, Zhang X, Yan D, Jiang D. Global burden and trends of rotavirus infection-associated deaths from 1990 to 2019: an observational trend study. Virol J 2022;19:166.
    doi: 10.1186/s12985-022-01898-9pmc: PMC9585833pubmed: 36266651google scholar: lookup
  4. Bennett A, Bar-Zeev N, Cunliffe NA. Measuring indirect effects of rotavirus vaccine in low income countries. Vaccine 2016;34:4351–4353.
    doi: 10.1016/j.vaccine.2016.07.001pmc: PMC5047945pubmed: 27443593google scholar: lookup
  5. Kim AH, Hogarty MP, Harris VC, Baldridge MT. The complex interactions between rotavirus and the gut microbiota. Front Cell Infect Microbiol 2020;10:586751.
    doi: 10.3389/fcimb.2020.586751pmc: PMC7819889pubmed: 33489932google scholar: lookup
  6. Otero CE, Langel SN, Blasi M, Permar SR. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries. PLoS Pathog 2020;16:e1009010.
    doi: 10.1371/journal.ppat.1009010pmc: PMC7676686pubmed: 33211756google scholar: lookup
  7. Church JA, Rukobo S, Govha M, Gough EK, Chasekwa B. Associations between biomarkers of environmental enteric dysfunction and oral rotavirus vaccine immunogenicity in rural Zimbabwean infants. EClinicalMedicine 2021;41:101173.
    doi: 10.1016/j.eclinm.2021.101173pmc: PMC8605235pubmed: 34825149google scholar: lookup
  8. Bhavnani D, Goldstick JE, Cevallos W, Trueba G, Eisenberg JNS. Synergistic effects between rotavirus and coinfecting pathogens on diarrheal disease: evidence from a community-based study in northwestern Ecuador. Am J Epidemiol 2012;176:387–395.
    doi: 10.1093/aje/kws220pmc: PMC3499114pubmed: 22842722google scholar: lookup
  9. Vlasova AN, Amimo JO, Saif LJ. Porcine Rotaviruses: epidemiology, immune responses and control strategies. Viruses 2017;9:48.
    doi: 10.3390/v9030048pmc: PMC5371803pubmed: 28335454google scholar: lookup
  10. Nemoto M, Hata H, Higuchi T, Imagawa H, Yamanaka T. Evaluation of rapid antigen detection kits for diagnosis of equine Rotavirus infection. J Vet Med Sci 2010;72:1247–1250.
    doi: 10.1292/jvms.10-0064pubmed: 20453452google scholar: lookup
  11. Otto PH, Rosenhain S, Elschner MC, Hotzel H, Machnowska P. Detection of rotavirus species A, B and C in domestic mammalian animals with diarrhoea and genotyping of bovine species A Rotavirus strains. Vet Microbiol 2015;179:168–176.
    doi: 10.1016/j.vetmic.2015.07.021pubmed: 26223422google scholar: lookup
  12. Bailey KE, Gilkerson JR, Browning GF. Equine rotaviruses--current understanding and continuing challenges. Vet Microbiol 2013;167:135–144.
    doi: 10.1016/j.vetmic.2013.07.010pmc: PMC7117381pubmed: 23932076google scholar: lookup
  13. Garaicoechea L, Miño S, Ciarlet M, Fernández F, Barrandeguy M. Molecular characterization of equine rotaviruses circulating in Argentinean foals during a 17-year surveillance period (1992-2008). Vet Microbiol 2011;148:150–160.
    doi: 10.1016/j.vetmic.2010.08.032pubmed: 20943330google scholar: lookup
  14. Dickson J, Smith VW, Coackley W, McKean P, Adams PS. Rotavirus infection of foals. Aust Vet J 1979;55:207–208.
    doi: 10.1111/j.1751-0813.1979.tb15293.xpubmed: 223542google scholar: lookup
  15. Imagawa H, Sekiguchi K, Anzai T, Fukunaga Y, Kanemaru T. Epidemiology of equine rotavirus infection among foals in the breeding region. J Vet Med Sci 1991;53:1079–1080.
    doi: 10.1292/jvms.53.1079pubmed: 1790219google scholar: lookup
  16. Slovis NM, Elam J, Estrada M, Leutenegger CM. Infectious agents associated with diarrhoea in neonatal foals in central Kentucky: a comprehensive molecular study. Equine Vet J 2014;46:311–316.
    doi: 10.1111/evj.12119pmc: PMC7163618pubmed: 23773143google scholar: lookup
  17. Carossino M, Barrandeguy ME, Li Y, Parreño V, Janes J. Detection, molecular characterization and phylogenetic analysis of G3P[12] and G14P[12] equine rotavirus strains co-circulating in central Kentucky. Virus Res 2018;255:39–54.
    doi: 10.1016/j.virusres.2018.05.025pubmed: 29864502google scholar: lookup
  18. Barrandeguy M, Parreño V, Lagos Mármol M, Pont Lezica F, Rivas C. Prevention of rotavirus diarrhoea in foals by parenteral vaccination of the mares: field trial. Dev Biol Stand 1998;92:253–257.
    pubmed: 9580371
  19. Saif LJ, Fernandez FM. Group A rotavirus veterinary vaccines. J Infect Dis 1996;174 Suppl 1:S98–106.
    doi: 10.1093/infdis/174.supplement_1.s98pmc: PMC7110367pubmed: 8752298google scholar: lookup
  20. Carossino M, Vissani MA, Barrandeguy ME, Balasuriya UBR, Parreño V. Equine Rotavirus A under the one health lens: potential impacts on public health. Viruses 2024;16:130.
    doi: 10.3390/v16010130pmc: PMC10819593pubmed: 38257830google scholar: lookup
  21. Hakim MS, Gazali FM, Widyaningsih SA, Parvez MK. Driving forces of continuing evolution of rotaviruses. World J Virol 2024;13:93774.
    doi: 10.5501/wjv.v13.i2.93774pmc: PMC11229848pubmed: 38984077google scholar: lookup
  22. Zeller M, Nuyts V, Heylen E, De Coster S, Conceição-Neto N. Emergence of human G2P[4] rotaviruses containing animal derived gene segments in the post-vaccine era. Sci Rep 2016;6:36841.
    doi: 10.1038/srep36841pmc: PMC5107926pubmed: 27841357google scholar: lookup
  23. Manjate F, João ED, Mwangi P, Chirinda P, Mogotsi M. Genomic characterization of the rotavirus G3P[8] strain in vaccinated children, reveals possible reassortment events between human and animal strains in Manhiça District, Mozambique. Front Microbiol 2023;14:1193094.
    doi: 10.3389/fmicb.2023.1193094pmc: PMC10277737pubmed: 37342557google scholar: lookup
  24. Hoa-Tran TN, Nakagomi T, Vu HM, Nguyen TTT, Dao ATH. Evolution of DS-1-like G8P[8] Rotavirus A strains from vietnamese children with acute gastroenteritis (2014-21): Adaptation and loss of animal rotavirus-derived genes during human-to-human spread. Virus Evol 2024;10:veae045.
    doi: 10.1093/ve/veae045pmc: PMC11215986pubmed: 38952820google scholar: lookup
  25. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol 2004;78:10213–10220.
    doi: 10.1128/JVI.78.19.10213-10220.2004pmc: PMC516399pubmed: 15367586google scholar: lookup
  26. Hyser JM, Estes MK. Rotavirus vaccines and pathogenesis: 2008. Curr Opin Gastroenterol 2009;25:36–43.
    doi: 10.1097/MOG.0b013e328317c897pmc: PMC2673536pubmed: 19114772google scholar: lookup
  27. Ruiz MC, Cohen J, Michelangeli F. Role of Ca2+in the replication and pathogenesis of rotavirus and other viral infections. Cell Calcium 2000;28:137–149.
    doi: 10.1054/ceca.2000.0142pubmed: 11020376google scholar: lookup
  28. Gebert JT, Scribano FJ, Engevik KA, Philip AA, Kawagishi T. Viroporin activity from rotavirus nonstructural protein 4 induces intercellular calcium waves that contribute to pathogenesis. bioRxiv 2024:2024.05.07.592929.
    doi: 10.1101/2024.05.07.592929google scholar: lookup
  29. Domínguez-Oliva A, Hernández-Ávalos I, Martínez-Burnes J, Olmos-Hernández A, Verduzco-Mendoza A. The Importance of animal models in biomedical research: current insights and applications. Animals (Basel) 2023;13:1223.
    doi: 10.3390/ani13071223pmc: PMC10093480pubmed: 37048478google scholar: lookup
  30. Chepngeno J, Takanashi S, Diaz A, Michael H, Paim FC. Comparative sequence analysis of historic and current porcine Rotavirus C strains and their pathogenesis in 3-day-old and 3-week-old piglets. Front Microbiol 2020;11:780.
    doi: 10.3389/fmicb.2020.00780pmc: PMC7197332pubmed: 32395116google scholar: lookup
  31. ADAMS WR, KRAFT LM. Epizootic diarrhea of infant mice: indentification of the etiologic agent. Science 1963;141:359–360.
    doi: 10.1126/science.141.3578.359pubmed: 14011026google scholar: lookup
  32. Guerrero CA, Santana AY, Acosta O. Mouse intestinal villi as a model system for studies of rotavirus infection. J Virol Methods 2010;168:22–30.
    doi: 10.1016/j.jviromet.2010.04.010pubmed: 20403385google scholar: lookup
  33. Ramig RF. The effects of host age, virus dose, and virus strain on heterologous rotavirus infection of suckling mice. Microb Pathog 1988;4:189–202.
    doi: 10.1016/0882-4010(88)90069-1pubmed: 2848173google scholar: lookup
  34. Maffey L, Vega CG, Miño S, Garaicoechea L, Parreño V. Anti-VP6 VHH: an experimental treatment for Rotavirus A-associated disease. PLoS One 2016;11:e0162351.
    doi: 10.1371/journal.pone.0162351pmc: PMC5014449pubmed: 27603013google scholar: lookup
  35. Woodyear S, Chandler TL, Kawagishi T, Lonergan TM, Patel VA. Chimeric viruses enable study of antibody responses to human Rotaviruses in Mice. Viruses 2024;16:1145.
    doi: 10.3390/v16071145pmc: PMC11281508pubmed: 39066309google scholar: lookup
  36. Franco MA, Greenberg HB. Immunity to rotavirus infection in mice. J Infect Dis 1999;179 Suppl 3:S466–9.
    doi: 10.1086/314805pubmed: 10099121google scholar: lookup
  37. Carossino M, Balasuriya UBR, Thieulent CJ, Barrandeguy ME, Vissani MA. Quadruplex real-time TaqMan® RT-qPCR assay for differentiation of equine group A and B Rotaviruses and identification of group A G3 and G14 genotypes. Viruses 2023;15:1626.
    doi: 10.3390/v15081626pmc: PMC10459720pubmed: 37631969google scholar: lookup
  38. Ramakrishnan MA. Determination of 50% endpoint titer using a simple formula. World J Virol 2016;5:85–86.
    doi: 10.5501/wjv.v5.i2.85pmc: PMC4861875pubmed: 27175354google scholar: lookup
  39. Carossino M, Barrandeguy ME, Erol E, Li Y, Balasuriya UBR. Development and evaluation of a one-step multiplex real-time TaqMan® RT-qPCR assay for the detection and genotyping of equine G3 and G14 rotaviruses in fecal samples. Virol J 2019;16:49.
    doi: 10.1186/s12985-019-1149-1pmc: PMC6482509pubmed: 31023319google scholar: lookup
  40. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238–249.
    pubmed: 8350599
  41. Kwon T, Trujillo JD, Carossino M, Lyoo EL, McDowell CD. Pigs are highly susceptible to but do not transmit mink-derived highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b. Emerg Microbes Infect 2024;13:2353292.
    doi: 10.1080/22221751.2024.2353292pmc: PMC11132737pubmed: 38712345google scholar: lookup
  42. Coelho KI, Bryden AS, Hall C, Flewett TH. Pathology of rotavirus infection in suckling mice: a study by conventional histology, immunofluorescence, ultrathin sections, and scanning electron microscopy. Ultrastruct Pathol 1981;2:59–80.
    doi: 10.3109/01913128109031504pubmed: 16830450google scholar: lookup
  43. Offor E, Riepenhoff-Talty M, Ogra PL. Effect of malnutrition on rotavirus infection in suckling mice: kinetics of early infection. Proc Soc Exp Biol Med 1985;178:85–90.
    doi: 10.3181/00379727-178-41987pubmed: 2981423google scholar: lookup
  44. Hao P, Pang Z, Qu Q, Cui C, Jiang Y. A G3P[3] bat rotavirus can infect cultured human cholangiocytes and cause biliary atresia symptom in suckling mice. Virol Sin 2024;39:974–976.
    doi: 10.1016/j.virs.2024.09.009pmc: PMC11738784pubmed: 39326847google scholar: lookup
  45. Nemoto M, Inagaki M, Tamura N, Bannai H, Tsujimura K. Evaluation of inactivated vaccines against equine group A rotaviruses by use of a suckling mouse model. Vaccine 2018;36:5551–5555.
    doi: 10.1016/j.vaccine.2018.07.057pubmed: 30076106google scholar: lookup
  46. Offit PA, Clark HF. Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. J Infect Dis 1985;152:1152–1158.
    doi: 10.1093/infdis/152.6.1152pubmed: 2999254google scholar: lookup
  47. Coste A, Sirard JC, Johansen K, Cohen J, Kraehenbuhl JP. Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea. J Virol 2000;74:8966–8971.
    doi: 10.1128/jvi.74.19.8966-8971.2000pmc: PMC102092pubmed: 10982340google scholar: lookup
  48. Meier AF, Suter M, Schraner EM, Humbel BM, Tobler K. Transfer of anti-rotavirus antibodies during pregnancy and in Milk following maternal vaccination with a herpes simplex virus type-1 amplicon vector. Int J Mol Sci 2017;18:431.
    doi: 10.3390/ijms18020431pmc: PMC5343965pubmed: 28212334google scholar: lookup
  49. Xue M, Yu L, Jia L, Li Y, Zeng Y. Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model. Hum Vaccin Immunother 2016;12:2959–2968.
    doi: 10.1080/21645515.2016.1204501pmc: PMC5137547pubmed: 27435429google scholar: lookup
  50. Franco MA, Tin C, Greenberg HB. CD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice. J Virol 1997;71:4165–4170.
    doi: 10.1128/JVI.71.5.4165-4170.1997pmc: PMC191577pubmed: 9094702google scholar: lookup
  51. Malamba-Banda C, Mhango C, Benedicto-Matambo P, Mandolo JJ, Chinyama E. Acute rotavirus infection is associated with the induction of circulating memory CD4+ T cell subsets. Sci Rep 2023;13:9001.
    doi: 10.1038/s41598-023-35681-9pmc: PMC10238530pubmed: 37268634google scholar: lookup
  52. Knipping K, McNeal MM, Crienen A, van Amerongen G, Garssen J. A gastrointestinal rotavirus infection mouse model for immune modulation studies. Virol J 2011;8:109.
    doi: 10.1186/1743-422X-8-109pmc: PMC3061940pubmed: 21385425google scholar: lookup
  53. Angel J, Franco MA, Greenberg HB. Rotavirus immune responses and correlates of protection. Curr Opin Virol 2012;2:419–425.
    doi: 10.1016/j.coviro.2012.05.003pmc: PMC3422408pubmed: 22677178google scholar: lookup
  54. Sánchez-Tacuba L, Kawagishi T, Feng N, Jiang B, Ding S. The role of the VP4 attachment protein in rotavirus host range restriction in an In Vivo suckling mouse model. J Virol 2022;96:e0055022.
    doi: 10.1128/jvi.00550-22pmc: PMC9364800pubmed: 35862708google scholar: lookup
  55. Feng N, Lawton JA, Gilbert J, Kuklin N, Vo P. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest 2002;109:1203–1213.
    doi: 10.1172/JCI14397pmc: PMC150959pubmed: 11994409google scholar: lookup
  56. VanCott JL, Prada AE, McNeal MM, Stone SC, Basu M. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates. J Virol 2006;80:4949–4961.
    doi: 10.1128/JVI.80.10.4949-4961.2006pmc: PMC1472046pubmed: 16641286google scholar: lookup
  57. Du J, Lan Z, Liu Y, Liu Y, Li Y. Detailed analysis of BALB/c mice challenged with wild type rotavirus EDIM provide an alternative for infection model of rotavirus. Virus Res 2017;228:134–140.
    doi: 10.1016/j.virusres.2016.12.001pubmed: 27932206google scholar: lookup
  58. McNeal MM, Rae MN, Ward RL. Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J Virol 1997;71:8735–8742.
    doi: 10.1128/JVI.71.11.8735-8742.1997pmc: PMC192338pubmed: 9343232google scholar: lookup
  59. Ciarlet M, Estes MK, Barone C, Ramig RF, Conner ME. Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections. J Virol 1998;72:2341–2351.
    doi: 10.1128/JVI.72.3.2341-2351.1998pmc: PMC109534pubmed: 9499095google scholar: lookup
  60. Boshuizen JA, Reimerink JHJ, Korteland-van Male AM, van Ham VJJ, Koopmans MPG. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J Virol 2003;77:13005–13016.
    doi: 10.1128/jvi.77.24.13005-13016.2003pmc: PMC296055pubmed: 14645557google scholar: lookup
  61. Rollo EE, Kumar KP, Reich NC, Cohen J, Angel J. The epithelial cell response to rotavirus infection. J Immunol 1999;163:4442–4452.
    pubmed: 10510386
  62. Yan M, Su A, Pavasutthipaisit S, Spriewald R, Graßl GA. Infection of porcine enteroids and 2D differentiated intestinal epithelial cells with Rotavirus A to study cell tropism and polarized immune response. Emerg Microbes Infect 2023;12:2239937.
    doi: 10.1080/22221751.2023.2239937pmc: PMC10399479pubmed: 37483148google scholar: lookup
  63. Li Y, Liu D, Wang Y, Su W, Liu G. The importance of glycans of viral and host proteins in enveloped virus infection. Front Immunol 2021;12:638573.
    doi: 10.3389/fimmu.2021.638573pmc: PMC8116741pubmed: 33995356google scholar: lookup
  64. Semmes EC, Chen J-L, Goswami R, Burt TD, Permar SR. Understanding early-life adaptive immunity to guide interventions for pediatric health. Front Immunol 2020;11:595297.
    doi: 10.3389/fimmu.2020.595297pmc: PMC7858666pubmed: 33552052google scholar: lookup
  65. Perkins GA, Wagner B. The development of equine immunity: current knowledge on immunology in the young horse. Equine Vet J 2015;47:267–274.
    doi: 10.1111/evj.12387pubmed: 25405920google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.